TruthArchive.ai - Related Video Feed

In this video, the speaker addresses the current state of drug use for mental health problems, focusing on antidepressants, antipsychotics, and mood stabilizers. They challenge the belief that these medications correct an underlying chemical imbalance, arguing for a drug-centered model instead. The speaker discusses the historical development of the disease-centered model and the influence of pharmaceutical companies. They advocate for a more honest and collaborative approach to drug treatment. The issue of unpublished research and the addictive nature of psychotropic medications are also discussed. The importance of individuals taking control of their own health and seeking alternative treatments is emphasized. The Soteria project is mentioned as a potential alternative for treating psychosis without relying solely on medication. Additionally, the speakers highlight the significance of considering social factors in understanding mental health issues.

Laura Delano discusses her experience with psychiatric drugs, starting at age 13. She claims the "chemical imbalance" theory is a lie and that 66 million Americans are on these drugs. She describes Post-SSRI Sexual Dysfunction (PSSD) and the outrage she faced after sharing her story of getting off medication. Delano recounts being diagnosed with bipolar disorder at 14 and put on a cocktail of drugs, including antidepressants, mood stabilizers, and antipsychotics. She says she was told it was a lifelong, incurable condition. She says there are no objective tests for mental illness, only subjective observations. She describes feeling numb and disconnected while on the drugs, and experiencing physical side effects like digestive issues and weight fluctuations. Delano says the drugs impaired her ability to think critically and connect with others. She says she eventually realized the treatment was making her sicker. She highlights the lack of long-term safety studies and the dangers of polypharmacy. She advocates for informed consent and questions the motives of the mental health industry. She emphasizes the importance of community, empathy, and finding purpose as alternatives to medication. She says she experienced withdrawal symptoms when she stopped taking the drugs. She says she found purpose in sharing her story and helping others make informed choices.

Depression is not caused by a deficiency in a serotonin reuptake inhibitor, but rather a general deficiency in serotonin. Serotonin is made in the gut through methylation, and 90% of the body's serotonin resides there. Therefore, if there isn't enough serotonin in the gut, there won't be enough elsewhere in the body. Depression usually begins in the gut, not as an outside cluster of symptoms.

Speaker 0 discusses the effectiveness and limits of psychiatric treatment. They say: “How many patients have you been able to cure so far? I would say one.” They also state, “There are no real cures right now in psychiatry. I don’t know that any of us are ever completely cured of anything.” On biological tests for mental illness, they remark, “What kind of biological tests do we have available today for detecting mental illnesses? None. I always felt like I was throwing darts in the dark at my patients and had hurt some of them.” They list various medications, including “Lithium. Remeron is another one. Trazodone. Zagradog. Depakure, levothyroxine. Amexico. Equatroids. Depakure. Lithium. Ambien. You may need an antidepressant also with a with pempectomy.” They warn about safety, noting that “There is a reason that most psychiatric medications have black box warnings. Give them to the wrong person, and you can precipitate a disaster.” They acknowledge uncertainty in efficacy: “We don't know if I give you a medication if it is going to work or not. To a certain degree, it's trial and error.” The speaker claims, “I have cured none of my patients.” Finally, they question who benefits: “The people who makes the diagnosis.”

My name is Gwen Olsen, a former pharmaceutical industry veteran. The industry focuses on maintaining diseases, not curing them. Psychiatric drugs keep patients reliant on medications for life. Many drugs are no more effective than placebos, with exercise often proving more beneficial. The pharmaceutical industry prioritizes profit over patient well-being, pushing unnecessary medications. It's crucial to educate yourself on alternative health options to avoid becoming a lifelong pharmaceutical customer. Take charge of your health, share knowledge, and prevent loved ones from falling victim to unnecessary medications. Thank you. Translation: The speaker, Gwen Olsen, discusses the pharmaceutical industry's focus on maintaining diseases rather than curing them, highlighting the ineffectiveness of many drugs and the importance of educating oneself on alternative health options.

"You're in the same." "If if, you're depressed, you're not deficient in a serotonin reuptake inhibitor, right?" "You you're deficient generally in serotonin." "And serotonin is made in the gut through this process called methylation." "90% of the serotonin in our bodies resides in our gut." "So if you don't have it here, you can't have it here." "Right." "So depression rarely begins in an outside cluster of symptoms." "It usually begins in the gut."

Dr. Josef Duhring and Dr. Yosef (Doctor Yosef Duhring) discuss antidepressants and SSRIs, outlining perceived risks, data limitations, and long-term concerns, followed by practical guidance on tapering and contact information for a tapering clinic. Key side effects and risks cited - Common side effects: gastrointestinal issues (nausea, vomiting, diarrhea), changes in sleep (insomnia or drowsiness), headaches, nervousness, restlessness, dry mouth, sweating, tremors, sexual dysfunction, decreased libido, difficulty reaching orgasm, erectile dysfunction, appetite and weight changes (gain or loss). - Other reported effects: emotional blunting, feeling less like yourself, dizziness, balance issues (especially early in treatment), increased sweating, abnormal dreams. - Serious but rarer risks: suicidal thoughts or behaviors, particularly under age 25; serotonin syndrome (described as rare); heart rhythm changes at high doses with some SSRIs. - Behavioral effects: mania, psychosis, irritability, aggression; rare but potentially misdiagnosed as bipolar disorder; in some cases leading to escalation to lithium or antipsychotics. - Sleep and long-term effects: SSRI use diminishing sleep quality (less REM and deep sleep), resulting in fatigue and brain fog in long-term users. - Long-term data gaps: “there has never been a randomized control study that looked at them for over a year,” and “seventy percent of antidepressant users are on these drugs for two years or more.” Claims that there is no long-term data on sustained efficacy or safety beyond eight to twelve weeks. Efficacy and data concerns - Most drugs reach market based on eight-week studies; there is a reported two-point difference on a 52-point depression scale between the drug and placebo, which is described as clinically very low. - Outcomes most meaningful to patients (employment, relationships, life meaning) are not directly measured in standard trials, which focus on scale-based movement. - The claim is made that long-term efficacy remains unproven and that the long-term data are unavailable. Observations about prescription patterns and systemic factors - Online “pill mill” platforms allegedly enable easy access to SSRIs (Lexapro), sometimes without video chats, via online questionnaires, with rapid mail delivery. - The dose of prescription and patient interactions are affected by time constraints and economic incentives in healthcare delivery, leading to faster checklists and medication-based treatments rather than in-depth discussions of life context, relationships, or non-drug approaches. - An “unholy alliance” between the pharmaceutical industry and academic medicine is described: investigators may pursue drug trials for career advancement and publications funded by drug companies, potentially biasing conclusions in favor of medications. - The FDA’s stance is portrayed as influenced by this environment, with concerns about regulatory capture and inadequate critical evaluation of risks, including suicide risk data and withdrawal issues. Key long-term and withdrawal considerations - Long-term withdrawal: physicians are described as telling patients that antidepressant withdrawal is mild and resolves in two weeks, but tapering often requires one to two years to avoid withdrawal symptoms; many are tapered too quickly, leading to relapse or withdrawal challenges. - Tapers and recovery: the clinician reports patients improving emotionally during tapering, sometimes even before complete discontinuation; success depends on broader life health improvements (physical health, relationships, purpose) and careful, gradual reduction. Three major concerns observed with antidepressants (as described by Dr. Yosef) - They don’t work for many patients in the long term; diminished efficacy over time due to emotional blunting and neurochemical adaptation. - Behavioral and cognitive changes: potential for mania, psychosis, irritability, and misdiagnosis as bipolar disorder; risk of “drug-induced” psychiatric symptoms. - Toxicity and sleep: long-term blunting reduces emotional responsiveness; chronic sleep disruption and brain fog; long-term toxicity may underlie persistent symptoms after prolonged use. Clinical implications and guidance offered - For those considering antidepressants, emotions matter and should be explored beyond a chemical-imbalance narrative; discuss physical health, relationships, purpose, substances, and non-drug approaches (therapy, lifestyle changes) before relying on medication. - For those already on SSRIs, a careful, patient-guided taper is advised: slowly reduce dosages, use approaches such as liquid tapering to control precise reductions, and listen to one’s body to avoid withdrawal; a two-year taper may be necessary for many patients. - Coming off antidepressants can reveal or restore aspects of life and personality; benefits may appear during tapering as engagement and motivation return, but life circumstances must be addressed in parallel to avoid relapse. Contact information - Tapering clinic website: taperclinic.com (for patients in the U.S.; clinic claims to operate in about 15–16 states, covering roughly 70% of the population). - YouTube channel for further resources: Doctor Yosef (German version) with a free drug tapering training (about five hours) and guidance for working with a doctor. Speaker names - Dr. Yosef Duhring (referred to as Doctor Josef Duhring in the discussion) and Dr. Yosef (the same speaker) are cited; their experiences include FDA and industry roles and a tapering clinic specializing in antidepressant withdrawal and discontinuation.

SSRIs are widely used: "About fourteen percent of the population" and "probably between fifteen to twenty percent" after COVID. Despite this, "There's more suicides" and "the outcomes are actually getting worse." Prozac "changed history" by "modulating the serotonin system" through "blocking serotonin reuptake" and making people "numb or emotionally constricted." The "chemical imbalance" story was a story "sold to doctors and patients" to justify drugs; "No brain scans, no blood tests" and used in diagnosis. The FDA is "funded by the pharmaceutical industry through PDUFA" with "70% funding," prioritizing drug development over safety signals. The "PSSD" stands for "post SSRI sexual dysfunction" and is experienced by "70 percent" with "permanent sexual dysfunction," "genital anesthesia," "cognitive damage," "emotional blunting" and "the suicide rate in this population is through the roof." There are withdrawal risks with benzodiazepines and "protracted withdrawal" can cause "brain injury."

The serotonin system was heavily targeted by the pharmaceutical industry, but experts suggest we're experimenting with it without full understanding. A 2022 systemic review of serotonin research found "no convincing evidence that depression is associated with or caused by lower serotonin concentration or activity." The FDA is considering a black box warning on related medications to ensure proper informed consent, especially for pregnant women, and to better inform doctors. Some doctors are unaware of the information presented in the FDA panel. The goal is radical transparency, ensuring everyone has informed consent with complete information.

"About fourteen percent of the population" "Of the total population is currently taking an antidepressant medication." "Currently, yes." "it's probably between fifteen percent to twenty percent of the population." "That's I mean, compared to my childhood or even twenty five years ago, that's a massive increase." "It's an enormous increase. It's likely, you know, last statistics I looked at, I think it's about a 500% increase from where things were in in the nineties, in the early nineties." "No. There's actually more suicides. There's more disability from mental health problems, and teen suicide is higher as well." "What we're doing is not working on a national level." "I'm just gonna skip ahead to my opinion, then I'm gonna pull back. But that suggests that we should ban the drugs and imprison the people selling them."

In the last 52 years of documented school shootings in America committed by teenagers, 100% of them were on either an antidepressant or a barbiturate drug for anxiety. These drugs, like Prozac, Zoloft, and Xanax, are all published to increase the risk of suicide, violent behavior, and homicidal actions. For the last 52 years that we have been tracking and studying them, 100% of all school shooters were on drugs prescribed by medical doctors and brought to you by pharmacies like CVS and Walgreens.

The healthcare industry profits from our sickness, depression, and infertility, making chronic disease a lucrative business. Pharma and food industries are interconnected in fueling this cycle. We are encouraged to rely on pills, fear the system, and keep consuming.

The speaker describes over forty years of work with psychiatrists and notes that the voices schizophrenics hear are not true hallucinations. He argues that these voices follow very specific, predictable patterns—about 23 of them—and that frontline clinicians can observe them without advanced lab equipment. He contends that psychiatry did not originate the idea of a chemical imbalance as the cause of schizophrenia; rather, it was devised by Eli Lilly in the 1970s when there was no clear explanation for the voices. According to him, the chemical imbalance theory was created to provide a cause and to avoid looking foolish, and it required labs and extensive disproving to challenge. He claims that those who first proposed the chemical imbalance theory could not support it with solid evidence, and that only a few university researchers outside the so-called psychiatric establishment began to question it, finding no chemical imbalance and admitting they did not even know what the brain’s chemical balance should be. He asserts that there have been no studies confirming a chemical imbalance as the cause of schizophrenia and that the theory was fabricated to appear explanatory. The speaker then shifts to the nature of the voices themselves, describing them as consistently negative: they are insulting, abusive, destructive, anti-religious, and hostile toward religion and spirituality, including a dislike of the Bible and preachers, and they reject the Twenty-Third Psalm. He claims the voices foster and create negative emotion, which is the reason they produce rotten statements to the person hearing them—suggesting that the voices aim to undermine self-worth and provoke despair. According to the speaker, when people hear these voices and are attacked by them, their energy level drops to nothing after the voices leave, and they do not notice the decline in energy. They observe that energy was not used during the attack and wonder where it went. The speaker posits a one-to-one correspondence between the appearance of the voices and the vanishing of energy, concluding that the voices “take” emotional energy in this way. He asserts that the voices survive on negative emotional energy, turning emotional state negative before they can be sustained by it.

There is a lot of corruption in politics due to money, bribes, and backdoor deals. One major mistake was allowing drug companies to advertise on television, which only two countries, the United States and New Zealand, permit. These commercials often make exaggerated claims and list potential side effects very quickly. It's concerning how they can make something seem great one moment and then mention serious side effects like suicidal thoughts and rectal bleeding. Personally, I haven't taken many medications, but when I tried SSRIs, I found the last 20 seconds of the commercial more impactful than the rest, and I didn't experience any benefits from them.

Speaker 0 states that over 52 years of documented school shootings in America, a hundred percent of the shooters were teenagers on either an antidepressant or a barbiturate drug for anxiety. He claims that every antidepressant, including Prozac, Zoloft, Xanax, and all these antianxiety drugs and antidepressants, is published to increase the risk of suicide behavior actions and lead to violent and homicidal actions. He also asserts that a hundred percent of all shooters, across the documented history, were on drugs prescribed by their medical doctors, brought to you by CVS and Walgreens and others.

According to the speaker, 100% of documented school shootings in America over the past 52 years were committed by teenagers on either an antidepressant or a barbiturate drug for anxiety. The speaker claims that every antidepressant, including Prozac, Zoloft, and Xanax, as well as anti-anxiety drugs, are published to increase the risk of suicide, violent behavior, and homicidal actions. The speaker asserts that these drugs are prescribed by doctors and sold at pharmacies like CVS and Walgreens.

In 1955, there were 565,000 mentally ill people in state and county mental hospitals, with a disability rate of 141 in every 470 people. By 1987, when Prozac was introduced, the number of people on disability due to mental illness had increased to 1,250,000, with a disability rate of 1 in every 184. Since then, the United States has seen a significant rise in psychiatric medication sales, spending over $40 billion annually. The number of people on government disability due to mental illness has tripled to 4 million, with 850 adults being added daily. Additionally, the number of children receiving payments for mental disorders has increased from 16,200 to 600,000, with 250 children per day joining the disability program. This raises questions about whether the drug-based paradigm of care is contributing to this epidemic.

"You have to have a term in the diagnostic and statistical manual in order to then call it a disease and treat it as a disease and write prescription for it." "Now there are over 300." "There have been 294 diagnoses diseases discovered discovered in the last sixty years in men in psychiatry alone? It's a joke." "It's an epidemic of psychiatry that we are dealing with." "No free will." "It's all chemicals." "A chemical imbalance matches very well with the idea that you give a drug which restores the balance." "Nobody has yet measured, demonstrated, or created a test to show that somebody has a chemical imbalance in their brain, period." "It is not science. It's politics and economics." "Behavior control." "It is not science. It is not medicine."

Depression drugs cannot cure people, but they can influence certain symptoms like emotional numbness and reduced self-care. However, these drugs can also cause sexual dysfunction even after discontinuation. Overall, these drugs are deemed terrible and should not be used. Psychiatry is unique in the healthcare field as its leaders consistently lie about the capabilities of their drugs. This situation is disheartening.

"Antidepressants are causing permanent lifelong sexual dysfunction, including total genital numbness long after the patient has stopped taking the drug. Sometimes it's even completely permanent." "I'm personally speaking to a 23 year old woman at Vanderbilt University right now who is suffering with this exact thing." "This is the most heartbreaking shit I've ever heard in my life." "This total genital numbness cannot feel anything at all." "She's also experienced physical atrophy in her outward sexual organs." "There's a Reddit group." "It does 13,000 members, 958 contributions per week." "A recent study by doctor Irwin Goldstein, he actually examined the tissue of young men that were experiencing PSSD." "He said on the young men that he examined, they had the same tissue of someone in their seventies and above."

The speaker argues that psychiatry is a pseudo science and criticizes the use of drugs and psychiatric abuses. They mention the drugs Adderall and Ritalin, claiming that Ritalin is a street drug. They believe that psychiatric drugs only mask the problem and that there is no such thing as a chemical imbalance. The speaker also mentions postpartum depression and suggests that there are alternative ways to address mental health issues, such as vitamins and exercise. They criticize Brooke for not understanding the history of psychiatry. The other speaker acknowledges the potential for abuse but suggests that these treatments may work for some people.